BIOA
NASDAQ · Pharmaceuticals
Bioage Labs Inc
$8.20
-0.26 (-3.07%)
Open$8.40
Previous Close$8.46
Day High$8.50
Day Low$8.11
52W High$25.96
52W Low$4.84
Volume—
Avg Volume562.6K
Market Cap375.21M
P/E Ratio—
EPS$-2.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+60.2% upside
Current
$8.20
$8.20
Target
$13.14
$13.14
$9.99
$13.14 avg
$19.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 11.72M | 148.13M | 155.08M |
| Net Income | -105,076,775 | 34.83M | 38.64M |
| Profit Margin | -896.1% | 23.5% | 24.9% |
| EBITDA | -120,670,596 | 58.57M | 58.31M |
| Free Cash Flow | — | 41.37M | 59.47M |
| Rev Growth | — | -6.9% | -7.9% |
| Debt/Equity | 0.01 | 0.90 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,148.51 | -1.85% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $267.76 | -0.53% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $147.66 | -2.15% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.05 | +0.43% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.77 | -1.50% | 11.5 | 30.15B |